204 related articles for article (PubMed ID: 31236416)
1. Diabetes Mellitus and Its Cardiovascular Complications: New Insights into an Old Disease.
Sardu C; De Lucia C; Wallner M; Santulli G
J Diabetes Res; 2019; 2019():1905194. PubMed ID: 31236416
[No Abstract] [Full Text] [Related]
2. Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications.
Abdul-Ghani MA; Jayyousi A; DeFronzo RA; Asaad N; Al-Suwaidi J
Curr Vasc Pharmacol; 2019; 17(2):153-163. PubMed ID: 29032755
[TBL] [Abstract][Full Text] [Related]
3. Diabetes: Time for reconciliation between cardiologists and diabetologists.
Scheen AJ
Nat Rev Cardiol; 2016 Sep; 13(9):509-10. PubMed ID: 27411401
[No Abstract] [Full Text] [Related]
4. [Basal insulin has a "neutral effect" on cardiovascular events].
Overbeck P
MMW Fortschr Med; 2012 Jun; 154(12):24. PubMed ID: 22880290
[No Abstract] [Full Text] [Related]
5. Diabetes and coronary artery disease: not just a risk factor.
Grant PJ; Cosentino F; Marx N
Heart; 2020 Sep; 106(17):1357-1364. PubMed ID: 32499237
[No Abstract] [Full Text] [Related]
6. Cardiovascular risk and glycemic control.
Cheng AY; Leiter LA
CMAJ; 2009 Apr; 180(9):907-8. PubMed ID: 19398731
[No Abstract] [Full Text] [Related]
7. Obesity, Diabetes, and Cardiovascular Diseases: A Compendium.
Scherer PE; Hill JA
Circ Res; 2016 May; 118(11):1703-5. PubMed ID: 27230636
[No Abstract] [Full Text] [Related]
8. Novo Nordisk incretin and Cardiovascular Summit, Durban, June 2013.
Wagenaar P
Cardiovasc J Afr; 2013 Sep; 24(8):340. PubMed ID: 24240386
[No Abstract] [Full Text] [Related]
9. Oral hypoglycaemic agents, insulin resistance and cardiovascular disease in patients with type 2 diabetes.
Hemmingsen B; Lund SS; Wetterslev J; Vaag A
Eur J Endocrinol; 2009 Jul; 161(1):1-9. PubMed ID: 19369429
[TBL] [Abstract][Full Text] [Related]
10. Incretin-based therapy for type 2 diabetes: A real class effect?
Savarese G; Lund LH; Rosano GMC
Int J Cardiol; 2017 Jan; 227():141-142. PubMed ID: 27866064
[No Abstract] [Full Text] [Related]
11. [Update diabetes mellitus and cardiovascular diseases].
Otter W
MMW Fortschr Med; 2012 Apr; 154(7):95-8. PubMed ID: 22558884
[No Abstract] [Full Text] [Related]
12. [Intensive blood glucose lowering to reduce cardiovascular risk: pro].
Martin S
Dtsch Med Wochenschr; 2009 May; 134(20):1060. PubMed ID: 19421929
[No Abstract] [Full Text] [Related]
13. [Diabetes and the liver].
Herzig S; Roden M
Dtsch Med Wochenschr; 2013 Jun; 138(23):1204-6. PubMed ID: 23720171
[No Abstract] [Full Text] [Related]
14. Glucose lowering strategies and cardiovascular disease in type 2 diabetes - teachings from the TOSCA.IT study.
Vaccaro O; Masulli M; Riccardi G
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):722-726. PubMed ID: 29804832
[TBL] [Abstract][Full Text] [Related]
15. [Intensive blood glucose lowering to reduce cardiovascular risk: contra].
Marx N
Dtsch Med Wochenschr; 2009 May; 134(20):1061. PubMed ID: 19421930
[No Abstract] [Full Text] [Related]
16. Is glucose control important for prevention of cardiovascular disease in diabetes?
Mannucci E; Dicembrini I; Lauria A; Pozzilli P
Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S259-63. PubMed ID: 23882055
[No Abstract] [Full Text] [Related]
17. Management of type 2 diabetes for prevention of cardiovascular disease. An expert opinion of the Italian Diabetes Society.
Napoli R; Formoso G; Piro S; Targher G; Consoli A; Purrello F
Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):1926-1936. PubMed ID: 32928628
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of some antidiabetic drugs.
Med Lett Drugs Ther; 2017 Aug; 59(1527):136-138. PubMed ID: 28787745
[No Abstract] [Full Text] [Related]
19. [From cardiovascular risk to chronic heart failure].
Ertl G
Med Klin (Munich); 2003 Oct; 98 Suppl 1():17. PubMed ID: 14694837
[No Abstract] [Full Text] [Related]
20. [Diabetes screening and early therapy. Feasible and successful].
MMW Fortschr Med; 2010 Oct; 152(40):16. PubMed ID: 21053403
[No Abstract] [Full Text] [Related]
[Next] [New Search]
